Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2003
03/20/2003CA2459760A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions
03/20/2003CA2459515A1 Indole derivatives
03/20/2003CA2459310A1 Method and composition for treating immune complex associated disorders
03/20/2003CA2458029A1 Methods of treating cytokine mediated diseases
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/19/2003EP1293512A2 DNA encoding the baboon and cynomolgus macaque prostaglandin E2 receptor EP4 subtype
03/19/2003EP1293511A1 Canine liver cell growth factor
03/19/2003EP1293202A1 Remedies for degenerative arthritis
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292671A1 Method for obtaining characterised muscle-derived cell populations and uses
03/19/2003EP1292621A1 Compositions and methods for the endocytic presentation of immunosuppressive factors
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292608A2 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292590A1 Admantane derivatives
03/19/2003EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/19/2003EP1292568A2 Benzamide ligands for the thyroid receptor
03/19/2003EP1292340A1 Transfection system
03/19/2003EP1292323A1 Inhibition of smad3 to prevent fibrosis and improve wound healing
03/19/2003EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
03/19/2003EP1278528A4 Nucleoside analogs with carboxamidine-modified bicyclic base
03/19/2003EP1257281A4 Nucleoside analogs with carboxamidine modified monocyclic base
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1056768B1 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
03/19/2003EP0745094B1 Superagonists and antagonists of human il-6, and method for their selection
03/19/2003EP0702559B1 Multiple botulinum toxins for treating neuromuscular disorders and conditions
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404474A Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404399A Novel non-antigenic mucosal adjuvant formulation for modulating the effects of substances, including vaccine antigens in contact with mucosal body surface
03/19/2003CN1403474A Short peptide and medicine with short peptide as active component
03/19/2003CN1403468A Prepn of epimedium general flavone with osteoporosis resisting function
03/19/2003CN1403168A Medical composite biological bone cement powder, bone cement liquid and composite biological bore cement
03/19/2003CN1403159A Application of matrix metalloprotease tissue inhibitor in preparing medicine for preventing and treating arthritis
03/19/2003CN1403153A Water dispersive nano level bone morphogenetic protein injection prepn and its prepn process
03/19/2003CN1403141A Plaster for treating cervical spondylosis and lumbar vertebra disease
03/19/2003CN1403139A Externally applied Chinese medicine for treating osteoarthropathy and its prepn process
03/19/2003CN1403123A Notoginseng medicine for treating traumatic injury and its prepn
03/19/2003CN1403113A Medicine for invigorating kidney, promoting blood circulation and promoting skeleton formation and its prepn
03/19/2003CN1403111A Fracture-setting medicine
03/19/2003CN1403107A Pain-stopping bone-penetrating ointment and its prepn
03/19/2003CN1403101A Fracture-setting silky fowl ointment and its prepn
03/19/2003CN1403086A Coculine-phosphatide composite and its prepn
03/19/2003CN1403081A Application of tadins inhibiting formation of osteoclast
03/19/2003CN1103225C Plaster for treating osteophytosis
03/18/2003US6534674 Crystalline disodium pamidronate hydrate and process for preparing it
03/18/2003US6534655 Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity
03/18/2003US6534651 Substituted isoindolinone derivatives
03/18/2003US6534642 Isolated nucleic acid of given sequence encoding a protein; dysfunction of the human protein implicated in hyper/hypocalcemia, bone disorders, leukemia and cancer
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534498 Protease inhibitors
03/18/2003US6534478 Cyclic azapeptides with angiogenic effect
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534098 Paget's disease; osteoporosis
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/17/2003CA2403157A1 Dna encoding the baboon and cynomolgus macaque prostaglandin e2 receptor ep4 subtype
03/17/2003CA2403058A1 Dna encoding the chimpanzee prostaglandin e2 receptor ep4 subtype
03/13/2003WO2003020930A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS
03/13/2003WO2003020768A1 A method for the treatment or prevention of bone erosion
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020752A1 A peptide and the pharmaceuticals containing it
03/13/2003WO2003020751A2 Homing peptides
03/13/2003WO2003020721A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/13/2003WO2003020719A1 1,3-benzothiazinone derivatives and use thereof
03/13/2003WO2003020716A1 Piperidine derivatives useful as ccr5 antagonists
03/13/2003WO2003020715A1 Aminopyrrole compounds as antiinflammatory agents
03/13/2003WO2003020711A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
03/13/2003WO2003020700A2 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
03/13/2003WO2003020324A2 Methods for sterilizing preparations of digestive enzymes
03/13/2003WO2003020310A1 Preventives and/or remedies for diseases caused by endosteal microcirculatory disorders
03/13/2003WO2003020309A2 Compound
03/13/2003WO2003020304A2 Inflammation modulatory compound comprising an endomorphin
03/13/2003WO2003020301A1 Chromogranin a and fragments thereof for the treatment of diseases involving increased vascular permeability
03/13/2003WO2003020278A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
03/13/2003WO2003020269A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
03/13/2003WO2003020267A1 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
03/13/2003WO2003020031A1 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
03/13/2003WO2002088080A3 Dual inhibitors of pde 7 and pde 4
03/13/2003WO2002087513A3 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002072543A3 Rxr activating molecules
03/13/2003WO2002072033A3 Chronotherapeutic dosage forms containing glucocorticosteroid
03/13/2003WO2002068388A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/13/2003WO2002067760A3 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
03/13/2003WO2002058706A3 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
03/13/2003WO2002053519A3 Hydrophobic polyamine analogs and methods for their use
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003WO2002046412A3 Regulation of angiogenesis with zinc finger proteins
03/13/2003WO2002044380A3 Master bone formation transcription factor: compositions and methods of use
03/13/2003WO2002044128A3 Salicylate analogs as interleukin-4 antagonists
1 ... 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 ... 820